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Abstract
Background: Acute stroke treatment in mobile stroke units (MSU) is feasible and reduces 
time- to- treatment, but the optimal staffing model is unknown. We wanted to explore 
if integrating thrombolysis of acute ischemic stroke (AIS) in an anesthesiologist- based 
emergency medical services (EMS) reduces time- to- treatment and is safe.
Methods: A nonrandomized, prospective, controlled intervention study. Inclusion crite-
ria: age ≥18 years, nonpregnant, stroke symptoms with onset ≤4 h. The MSU staffing is 
inspired by the Norwegian Helicopter Emergency Medical Services crew with an anes-
thesiologist, a paramedic- nurse and a paramedic. Controls were included by conventional 
ambulances in the same catchment area. Primary outcome was onset- to- treatment time. 
Secondary outcomes were alarm- to- treatment time, thrombolytic rate and functional 
outcome. Safety outcomes were symptomatic intracranial hemorrhage and mortality.
Results: We included 440 patients. MSU median (IQR) onset- to- treatment time was 101 
(71– 155) minutes versus 118 (90– 176) minutes in controls, p = 0.007. MSU median (IQR) 
alarm- to- treatment time was 53 (44– 65) minutes versus 74 (63– 95) minutes in controls, 
p < 0.001. Golden hour treatment was achieved in 15.2% of the MSU patients versus 
3.7% in the controls, p = 0.005. The thrombolytic rate was higher in the MSU (81% vs 
59%, p = 0.001). MSU patients were more often discharged home (adjusted OR [95% CI]: 
2.36 [1.11– 5.03]). There were no other significant differences in outcomes.
Conclusions: Integrating thrombolysis of AIS in the anesthesiologist- based EMS reduces 
time- to- treatment without negatively affecting outcomes. An MSU based on the EMS 
enables prehospital assessment of acute stroke in addition to other medical and traumatic 
emergencies and may facilitate future implementation.
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INTRODUC TION
The emergency medical services (EMS) provides urgent prehospital 
treatment, stabilization and transportation in medical and traumatic 
emergencies, but diagnostic limitations lead to insufficient ability 
to detect and treat acute ischemic stroke (AIS). AIS is utterly time 
critical where small reductions in time to intravenous thrombolysis 
(IVT) lead to better outcomes [1– 3] but still a minority of AIS pa-
tients receive IVT and the treatment is rarely administered in the 
more effective time window − the golden hour [4]. Mobile stroke 
units (MSU) are ambulances equipped with a computed tomography 
(CT) scanner and staffed with a stroke team which enables prehos-
pital assessment of stroke [5,6]. MSUs are generally set up with an 
onboard stroke physician as the decision maker or a non- physician 
team relying on telemedical evaluation by an in- hospital stroke phy-
sician [5,7]. The different staffing models report time reductions, 
better outcomes and both increased thrombolytic rates and golden 
hour treatment [5,7,8].
The Norwegian Acute Stroke Prehospital Project (NASPP) was 
inspired by the Norwegian Helicopter Emergency Medical Services 
(HEMS), a nationwide anesthesiologist- staffed air ambulance ser-
vice, and staffed the MSU with an anesthesiologist trained in pre-
hospital critical care, a paramedic- nurse and a paramedic. Acute 
stroke assessment was added to the worklist of the physician- based 
EMS and the feasibility of such a model was explored. The study 
showed that the prehospital anesthesiologists effectively could in-
terpret cerebral CT scans and use the National Institutes of Health 
Stroke Scale (NIHSS), both with good agreement with in- hospital 
specialists [9,10]. Treat- NASPP, the follow- up study, added IVT to 
the procedure.
The aim of Treat- NASPP was to explore if IVT administered by 
an anesthesiologist in an MSU reduces time- to- treatment and is safe 
[11]. We hypothesized that the model reduces onset- to- treatment 
time (OTT) with ≥15 minutes without negatively affecting outcomes 
[11].
METHODS
Treat- NASPP is a single- center, nonrandomized, prospective, con-
trolled intervention study conducted in Southeast Norway, Østfold 
county, comparing AIS treatment in an MSU with standard in- 
hospital care. The county covers about 4000 km2 (1550 miles2), has 
approximately 300 000 residents and one primary stroke center 
(PSC). The largest city in the county, Fredrikstad, has about 83 000 
inhabitants. The nearest comprehensive stroke center (CSC) is in 
Oslo, 90 km (55 miles) north of the PSC. The county has five ambu-
lance stations situated from 7 to 50 km (5 to 31 miles) from the PSC. 
As a precaution against delay, the MSU was only allowed to enroll 
patients situated ≥10 minutes driving distance from the PSC (Figure 
S1). The MSU was based at the ambulance station in Sarpsborg, 
which is within the 10- minute exclusion zone and the station closest 
to the PSC (Figure S1).
Trial design
The MSU enrolled patients consecutively on weekdays 08:00 hours 
to 20:00 hours (on- hours) 2 weeks per month except during main-
tenance, weekends and public vacations due to logistical and eco-
nomical limitations. Controls were recruited by ordinary ambulances 
weekdays, 08:00 hours to 20:00 hours, 2 weeks per month when the 
MSU was not operative, except weekends and vacations. A lower 
enrollment than expected led to a deliberate change in procedure 
where (i) inclusion in both groups was extended to all weekdays from 
February 2018, (ii) control group inclusion also in weekends and va-
cations from April 2018 and (iii) a 24– 7 inclusion in the control group 
from January 2019. After the changes in February 2018, both the in-
tervention group and control group enrolled weekdays 08:00 hours 
to 20:00 hours, but the MSU enrollment was prioritized. Control pa-
tients were included in MSU on- hours if the MSU was preoccupied 
or not operative.
Inclusion criteria were age ≥18 years, nonpregnant and stroke 
symptoms lasting ≤4 h. The emergency medical communication 
center (EMCC) used the Norwegian Index of Emergency Medical 
Assistance as a decision tool for the appropriate response [12]. The 
MSU was always dispatched in parallel with an ordinary ambulance 
due to the known inaccuracy in stroke code dispatches [13] and to 
effectively cooperate between the five ambulance stations without 
causing prehospital delay. The rendezvous approach was applied 
when appropriate.
Intervention
An MSU (Mercedes Sprinter) equipped with a CT scanner (CereTom® 
eight- slice mobile CT; Samsung NeuroLogica), a ventilator (LTV 
1200; Carefusion, Diacor AS), a defibrillator (Lifepak 15; Physio 
Control) and a point- of- care laboratory (pocH- 100i Automated 
Hematology Analyzer). Hemochron Jr (ITC Edison) and CoaguChek 
Pro II (Roche Diagnostic, AlereTM) measured international normal-
ized ratio. Meytec (Werneuchen) used telecommunication by 4G for 
transmission of images and data from the CT.
The Treat- NASPP MSU was staffed like the nationwide HEMS 
with an anesthesiologist trained to provide prehospital critical care 
to critically ill patients including acute stoke. The additional team 
members were a paramedic- nurse and a paramedic. The 11 par-
ticipating anesthesiologists had median (IQR) 14 (12– 15) years of 
clinical training, 10 (8– 13) years anesthesiology training and 2 (0– 9) 
years of prehospital work experience. The anesthesiologists work 
with medical emergencies in the HEMS and/or in intensive care 
units. In- hospital anesthesiologists are involved in the reception of 
critically ill patients arriving in the emergency department and the 
participating anesthesiologists have experience in treating medical 
and traumatic emergencies including stroke.
The EMS in Norway is a government funded, non- physician- 
based system where ambulances are staffed with two paramedics 
[14]. The education of ambulance personnel is either (i) a 3- year 
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bachelor program in Paramedic Science, (ii) a 2- year high school edu-
cation along with 2 years EMS practice or (iii) ambulance worker au-
thorization of nurses after 2 years work in the EMS and completion 
of compulsory advanced life support courses. Regarding the MSU, 
the first two groups are referred to as paramedics and the third 
group referred to as a paramedic- nurse since they have different 
work tasks.
All MSU personnel completed a 2- day stroke assessment course 
and an NIHSS certification [15]. The anesthesiologists completed 
a 2- day course in cerebral CT assessment relying on the validation 
done in the previous NASPP study [10,16]. The course included 
interpretation of CT scans regarding contraindications for IVT, CT 
calibration, conduction of CT scans and radiation safety. As a daily 
start- up routine, the anesthesiologist conducted a CT calibration, a 
CT quality assurance and a CT scan of a head phantom which was 
sent teleradiologically to the in- hospital radiographer as a safety 
check of technical systems, image quality and the teleradiology 
system. A green light in the front of the MSU indicated good 4G 
connectivity. In case of connectivity problems, the anesthesiologist 
could try to resend the images, move the MSU to a place with better 
connectivity or abort mission and transport the patient to the PSC.
The paramedic, who was the MSU driver, planned the meet-
ing point if it was a rendezvous dispatch and prepared for recep-
tion of the patient by leveling the MSU, preparing the stretcher 
and assisting the paramedic- nurse. The paramedic- nurse prepared 
for blood sampling and medication before the patient arrived. The 
paramedic- nurse drew blood samples, measured vital signs, adminis-
tered medication if indicated and assisted the anesthesiologist. The 
anesthesiologist checked vital signs, medical history and NIHSS. If 
indicated, a cerebral CT scan and blood analysis were conducted. 
CT images were transferred for a second interpretation by the on- 
call radiologist, and the on- call neurologist was conferred for a final 
agreement on IVT indication. Tissue plasminogen activator (tPA) was 
administered according to in- hospital procedures. From November 
27, 2017 a direct triage algorithm agreement with the CSC was 
established to further reduce time- to- treatment in both cerebral 
hemorrhages and large vessel occlusions (LVO). Patients with non- 
traumatic subarachnoid hemorrhage (SAH) or surgically available in-
tracranial hemorrhage (ICH) in benefiting patients (evaluating frailty, 
prognosis, hematoma size and location) were transported directly to 
the CSC. All patients with NIHSS ≥6 or aphasia and a non- contrast 
cerebral CT without hemorrhage were considered as possible LVO 
and were evaluated for direct transportation to the CSC (Figure S2).
Control
Controls were initially recruited by 10 paramedics working in ordi-
nary ambulances. Due to a lower recruitment than expected, this 
group was increased to 63 in November 2018. All completed a 2- day 
course in acute stroke assessment and an NIHSS certification [15]. 
The course was based on the training program for prehospital per-
sonnel validated in NASPP, [9] and the training was done to optimize 
the control group. In November 2018, low recruitment led to a de-
liberate change in procedure where all other ambulance personnel in 
the county (n = 230) could enroll patients.
Outcomes
The primary outcome was to determine the difference in OTT be-
tween the intervention and control group. A power analysis (two- 
sample, two- sided, power 0.80) determined a sample size of 86 
thrombolyzed patients in each group to confirm a 30- minute differ-
ence in OTT [10,11].
Secondary outcomes were alarm- to- treatment time (ATT), 
thrombolytic rate and functional outcome (modified Rankin Scale 
[mRS]). The thrombolytic rate was defined as the proportion of 
patients with a final hospital diagnose of cerebral ischemia (AIS, 
transient ischemic attack [TIA]) receiving IVT within the 4.5- h time 
window. TIA was included in the thrombolytic rate as all patients 
had ongoing stroke symptoms at time of inclusion and when IVT was 
initiated. If symptoms resolved within 24 h and radiological workup 
was negative, a TIA diagnosis was registered at the PSC. The PSC did 
not have a routine for registering averted strokes.
As mRS at discharge was rarely registered, discharge- to- home 
was used as a surrogate. The follow- up mRS was collected by a tele-
phone interview 3 months (±1 week) after IVT. The registrars were 
certified in mRS assessment and blinded for study group [17].
Safety endpoints included symptomatic intracranial hemorrhage 
(SICH), serious adverse events (SAE) and mortality three months after 
IVT. An SAE was defined as complications following IVT leading to death, 
intensive care treatment, transfusion or surgery. SICH was defined as 
local or remote parenchymal hemorrhage type 2 on the 22– 36 h post- 
treatment scan, combined with a deterioration in NIHSS of ≥4 from 
baseline or the lowest NIHSS between baseline and 24 h or leading to 
death SITS-MOST, [18] or a significant worsening of symptoms linked to 
the cerebral bleeding [11]. Safety parameters were reported to an exter-
nal safety committee of two experienced neurologists. The committee 
was blinded for study group and could stop the study if they found evi-
dence for an unacceptable increase in SICH (>4%) or deaths [11].
Statistical methods
Data were run through intention- to- treat analyses in IBM SPSS 
Version 27 and R 4.0.3. A significance level of 0.05 was used. 
Continuous variables were skewed and compared with Mann−
Whitney U test. Categorical variables were compared using 
Pearson's Chi- squared test or Fisher exact test.
Modified Rankin Scale (mRS) was analyzed as an ordinal scale (0– 
6) and dichotomized where mRS 0– 2 was defined as favorable out-
come (functionally independent). Associations between study group 
and outcomes were tested in adjusted and unadjusted binary logistic 
regression. Predictors were selected by univariate analysis and clini-
cal evaluation. These predictors (age, sex, study group, initial NIHSS, 
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baseline mRS, atrial fibrillation, LVO, hypertension, EVT) were used in 
a stepwise logistic regression to find the best model. When forward 
and backward regression resulted in different models, we used Akaike 
information criterion to select the optimal model (see Table 3).
Ethics
The Regional Ethics Committee approved the study protocol (Ref. 
2016/974) [11]. Written informed consent was obtained from the 
participating person or a legally authorized representative.
RESULTS
The study started May 15, 2017 and terminated March 27, 2020 
after reaching the required sample size. Follow- up was finalized in 
June 2020. The MSU included 166 patients in 456 operative days 
(Figure 1), and 86% were rendezvous dispatches. Direct triage was 
performed in 19 patients (Figure S2). Technical problems (n = 2) and 
disrupted teleradiological connectivity (n = 4) hindered prehospital 
CT evaluations in six cases. The control group included 274 patients 
in 771 study- operative days (Figure 1).
The MSU patients were median (IQR) 72 (57– 83) years and 40% 
were females (Table 1). The control patients were median (IQR) 72 
(60– 81) years and 49% were females (Table 1). The baseline char-
acteristics were balanced except for initial NIHSS (Table 1). The 
median (IQR) scene- to- hospital time was 20 (15– 30) minutes in 
the MSU group and 20 (13– 27) minutes in the controls, p = 0.036 
(Table 1).
The median (IQR) OTT was 101 (71– 155) minutes in the MSU 
(n = 92) versus 118 (90– 176) in controls (n = 107), p = 0.007 (Table 2). 
The median (IQR) ATT was 53 (44– 65) minutes in the MSU versus 74 
(63– 95) in controls, p < 0.001 (Table 2). The thrombolytic rate was 
81% in the MSU versus 59% in controls, p = 0.001) (Table 2). Ten of 
the MSU patients received in- hospital IVT (Table S1).
Ultraearly thrombolysis ≤60 minutes after symptom onset 
was four- fold higher in the MSU (15.2% vs 3.7%, p = 0.005), which 
corresponds to a relative risk (95% CI) of 4.1 (1.4– 11.9) (Table 2, 
Figure 2). A sensitivity analysis for patients outside the exclusion 
zone showed a 13- fold higher golden hour rate in the MSU (15.2% 
vs 1.2%, p = 0.001), which corresponds to a relative risk (95% CI) of 
12.9 (1.7– 96.3) (Table 2). Forty- two percent of the MSU patients 
had an OTT ≤90 minutes compared to 25% in the controls, p = 0.010 
(Table 2, Figure 2). Sensitivity analyses for on- hour patients and pa-
tients situated outside the exclusion zone are presented in Table 2.
F I G U R E  1  Study flow chart showing 
enrollment in the intervention and control 
group. EMS, emergency medical services; 
IVT, intravenous thrombolysis; MSU, 
mobile stroke unit
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There were no differences in mRS categories (0– 6) between 
the groups at 3 months, p = 0.637 (Figure 3). Adjusted odds ratio 
(OR) for discharge- to- home was higher in the MSU (2.36 [1.11– 
5.03]). No other significant differences in outcomes were found 
(Table 3).
DISCUSSION
Introducing IVT in the anesthesiologist- based EMS significantly 
reduced OTT and increased ultraearly thrombolysis and the 
thrombolytic rate without any safety concerns compared to in- 
hospital treatment. This is a report from the first operative MSU in 
the Nordic countries and one of only a few MSU studies conducted 
in a nonurban area [19– 21].
OTT was 17 minutes shorter in the MSU and more than 40% 
of the MSU patients were treated within 90 minutes from symp-
tom onset. The time reductions achieved are reliant on: (i) accurate 
communication and coordination between the MSU, EMCC, ambu-
lances and the PSC, (ii) a well- coordinated stroke team in the MSU 
and (iii) maintained technical systems. The reported time reductions 
are clinically relevant as for every 15- minute delay in OTT there is a 
TA B L E  1  Baseline characteristics, time intervals and discharge information compared between the mobile stroke unit and the controls
Baseline characteristics MSU (n = 166) MP Control (n = 274) MP
P 
value
Females, %, n 40 (66) 49 (135) 0.052
Age, years, median (IQR) 72 (57– 83) 72 (60– 81) 0.620
Thrombolysis, % (n) 55 (92) 39 (107) 0.001
Comorbidities
Heart disease, % (n) 32 (53) 40 (109) 0.098
Hyperlipidemia, % (n) 23 (37) 4 17 (46) 7 0.154
Atrial fibrillation, % (n) 13 (21) 1 17 (46) 1 0.245
Hypertension, % (n) 55 (92) 56 (153) 0.932
Diabetes, % (n) 13 (22) 1 16 (43) 1 0.490
Smoking, % (n) 18 (28) 13 19 (47) 29 0.827
Cerebrovascular disease, % (n) 28 (47) 28 (77) 0.962
Stroke severity
NIHSS, median (IQR) 4 (2– 8) 3 2 (1– 6) 13 <0.001
NIHSS 0– 5, % (n) 65 (106) 3 73 (190) 13 0.090
NIHSS 6– 14, % (n) 23 (37) 3 20 (53) 13 0.558
NIHSS ≥15, % (n) 12 (20) 3 7 (18) 13 0.060
Onset to alarm, min, median (IQR) 43 (13– 95) 32 (10– 78) 0.057
Alarm- rendezvous, min, median, (IQR) 29 (24– 36) 24 NA
MSU scenea  to CT, min, median, (IQR) 11 (8– 16) 1 NA
Scenea  to hospital, min, median (IQR) 20 (15– 30)b  1 20 (13– 27) 3 0.036
Premorbid living home, % (n) 95 (154) 3 90 (245) 3 0.131
Discharged home, % (n) 67 (108) 4 62 (166) 6 0.323
Survival day 7, % (n) 96 (159) 97 (265) 0.613
Survival day 90, % (n) 89 (146) 1 92 (252) 0.224
Discharge diagnoses
AIS, % (n) 35 (58) 37 (101) 0.684
TIA, % (n) 15 (25) 14 (39) 0.812
ICH, % (n) 6 (10) 7 (19) 0.709
SAH, % (n) 2 (3) 1 (3) 0.677
Other, % (n) 42 (70) 41 (112) 0.790
Abbreviations: AIS, acute ischemic stroke; CT, computed tomography; ICH, intracerebral hemorrhage; IQR, interquartile range; MP, missing patients; 
MSU, mobile stroke unit; NA, not available; NIHSS, National Institutes of Health Stroke Scale; SAH, subarachnoid hemorrhage; TIA, transient 
ischemic attack.
aScene is initial patient site or rendezvous site.
bAs 86% of the MSU dispatches were rendezvous, the actual scene- to- hospital time was longer as the ambulance transportation time from initial 
patient site to rendezvous site must be considered.
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decline in functional outcome, [4] and the number- needed- to- treat 
increases rapidly after the first 90 minutes [1]. In the present study, 
the MSU patients were more often discharged home (adjusted OR 
2.36 [1.11– 5.03]), but we found no significant differences in other 
outcomes (Table 3). The study was not powered for detection of dif-
ferences in outcome, so the lack of these results could be expected.
Golden hour treatment gives higher odds of early neurological 
improvement, complete recanalization and favorable functional out-
come [2,4,22] but still in- hospital golden hour treatment is reported 
to be as low as 1%– 2% [4,22,23]. Treat- NASPP confirms that prehos-
pital assessment of acute stroke by an anesthesiologist- based EMS 
team can increase the golden hour rate. The MSU also followed a 
TA B L E  2  Characteristics and outcomes in thrombolyzed patients
Characteristics and outcomes MSU(n = 92) MP Control(n = 107) MP
P 
value
Age, year, median, (IQR) 72 (62– 83) 74 (64– 82) 0.775
Females, % (n) 46 (42) 52 (56) 0.347
Premorbid living home, % (n) 95 (86) 1 89 (95) 0.152
Initial NIHSS, median, IQR 4 (3– 8) 4 (2– 7) 0.178
Days in stroke unit, median (IQR) 4 (2– 6) 4 (3– 6) 0.875
Discharged home, % (n) 69 (63) 59 (62) 1 0.146
OTT, min, median (IQR) 101 (71– 155) 118 (90– 176) 0.007
ATT, min, median (IQR) 53 (44– 65) 74 (63– 95) <0.001
DNT, min, median (IQR) 22 (14– 28) 29 (25– 36) <0.001
Alarm- to- CT, min, median (IQR) 38 (31– 46) 54 (42– 69) <0.001
Golden hour, % (n) 15.2 (14) 3.7 (4) 0.005
OTT ≤90 min, % (n) 42 (39) 25 (27) 0.010
Thrombolytic rate, % (n) 81 (67) 59 (82) 0.001
Discharge diagnosesa 
AIS, % (n) 53 (49) 66 (71) 0.060
TIA, % (n) 20 (18) 10 (11) 0.064
Other, % (n) 27 (25) 23 (25) 0.537
Outcomes
mRS 0– 2 baseline, % (n) 84 (76) 2 92 (97) 2 0.081
mRS 0– 2 day 90, % (n) 70 (64) 1 74 (78) 2 0.536
mRS day 90, median (IQR) 1 (0– 3) 1 0 (0– 3) 2 0.554
Survival day 7, % (n) 97 (89) 98 (105) 0.664
SICH, % (n) 2.2 (2) 1.9 (2) 1.000
SAE, % (n) 3.3 (3) 2.8 (3) 1.000
Mortality day 90, % (n) 8.7 (8) 3.7 (4) 0.143
Sensitivity analyses
On- hour patients,b n MSU, 92 Control, 47
OTT, min, median (IQR) 101 (71– 155) 127 (87– 198) 0.023
ATT, min, median (IQR) 53 (44– 65) 73 (60– 98) <0.001
DNT, min, median (IQR) 22 (14– 28) 27 (22– 37) <0.001
Patients outside exclusion zone,c  n MSU, 92 Control, 85
OTT, min, median (IQR) 101 (71– 155) 115 (91– 181) 0.005
ATT, min, median (IQR) 53 (44– 65) 78 (69– 98) <0.001
Golden hour, % (n) 15.2 (14) 1.2 (1) 0.001
Abbreviations: AIS, acute ischemic stroke; ATT, alarm- to- treatment time; CT, computed tomography; DNT, door- to- needle time; IQR, interquartile 
range; MP, missing patients; mRS, modified Rankin Scale; MSU, mobile stroke unit; NIHSS, National Institutes of Health Stroke Scale; OTT, onset- to- 
treatment time; SAE, serious adverse event; SICH, symptomatic intracranial hemorrhage; TIA, transient ischemic attack.
a Sum not 100% due to rounding of numbers.
b Patients enrolled weekdays 08:00 hours to 20:00 hours.
c The exclusion zone was a 10- minute driving time radius around the primary stroke center where the MSU was not allowed to enroll patients.
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CSC triage algorithm for hemorrhages and suspected LVO to further 
reduce time- to- treatment (Figure S2). The accuracy of prehospital 
triage would increase if cerebral CT angiography was performed on 
the MSU [24] but this was not available in our study.
The thrombolytic rate in the MSU was significantly higher than 
in the controls and higher than in other MSU studies [5]. Assessment 
and treatment in the field increases the possibility that late present-
ing patients can be treated within the time limit thus increasing the 
thrombolytic rate.
Stroke mimics were included in our analyses as reports on mim-
ics in other MSU studies are sparse, and as mimics are a real part of 
hyperacute stroke evaluations (Figure S3). Forty percent of stroke 
dispatches in Treat- NASPP were for non- stroke patients, which is 
similar to previous reports [25,26]. The mimic rate of IVT- treated pa-
tients were not significantly different between the groups (Table 2). 
No complications were registered in these patients, which is in line 
with research showing that IVT in mimics is safe [27]. Regional and 
liberal indications for IVT may have contributed to both high mimic 
rates and high thrombolytic rates − a main goal of treating all eligi-
ble AIS patients, no lower NIHSS limit, no upper age limit and short 
door- to- needle time (DNT) [28].
The NASPP studies introduce an alternative MSU model based 
on the Norwegian nationwide HEMS which may be a benefit in a re-
ality where almost half of stroke code dispatches are for non- stroke 
patients [13]. A crew that can respond to all medical and traumatic 
emergencies may also be a benefit in suburban/rural areas where 
the population and stroke incidence is lower. As a safety precaution 
the anesthesiologist had to confer with the in- hospital neurologist 
before initiating tPA and this often led to a decision delay. The future 
perspective, based upon results from the NASPP and Treat- NASPP 
studies [9,10] must be that the MSU becomes an autonomous unit 
with onboard digital access to medical records where the anesthesi-
ologist independently interprets CT images and decides the indica-
tion for IVT. Clinical, health economical and geospatial studies will 
be necessary to develop tailor- made solutions for prehospital treat-
ment of acute stroke.
F I G U R E  2  Symptom onset to treatment intervals. The 
proportion of patients treated within each time interval in the 
mobile stroke unit (MSU) and control group. More patients in the 
MSU are treated within the first 60 and 90 min after symptom 
onset. In the control group the sum is not 100% due to rounding of 
numbers
F I G U R E  3  Distribution of modified Rankin Scale (mRS) scores 
for thrombolyzed patients at 90 days. MSU, mobile stroke unit. In 
the MSU group the sum is not 100% due to rounding of numbers
Variable
Univariable Multivariable
OR (95% CI) MP OR (95% CI) MP
Binary logistic regression
mRS 0– 2 day 90 0.82 (0.44– 1.54) 3 1.07a  (0.41– 2.83) 6
Discharged home 1.54 (0.86– 2.77) 1 2.36b  (1.11– 5.03) 9
SICH 1.17 (0.16– 8.45) 0 0.95c  (0.12– 7.34) 0
Mortality day 90 2.45 (0.71– 8.43) 0 2.07d  (0.50– 8.62) 0
The outcome analyses were conducted for thrombolyzed patients.
Abbreviations: CI, confidence interval; MP, missing patients; mRS, modified Rankin Scale; MSU, 
mobile stroke unit; NIHSS, National Institutes of Health Stroke Scale; OR, odds ratio; SICH, 
symptomatic intracranial hemorrhage.
aAdjusted for age, gender, initial NIHSS, baseline mRS, atrial fibrillation.
bAdjusted for age, initial NIHSS, baseline mRS, hypertension, large vessel occlusion.
cAdjusted for initial NIHSS.
dAdjusted for age, initial NIHSS.
TA B L E  3  Unadjusted and adjusted 
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Treat- NASPP has limitations and a nonrandomized study is more 
susceptible to bias. Control patients were recruited also in the MSU's 
off- hours (Table 2). As the MSU had a 10- minute exclusion zone 
from the PSC (Figure S1) and most dispatches were rendezvous, the 
time reductions and recruitment were affected (Table 2). Low inclu-
sion rates in both groups were due to few operative periods, enroll-
ment based on too few paramedics working in on- off periods and a 
suburban/rural area with few stroke dispatches. Training ambulance 
personnel in acute stroke assessment could impact the results in the 
control group. Follow- up mRS was a prespecified secondary out-
come, but the study was underpowered for this endpoint. This study 
provides mainly safety data and the findings cannot be generalized 
to anesthesiologists (or other specialists) without specific training.
The Treat- NASPP MSU model, with an anesthesiologist- based 
EMS team, reduces time to thrombolytic treatment and increases 
ultraearly thrombolytic therapy in AIS without negatively affect-
ing functional outcomes or safety outcomes. Utilizing the exist-
ing physician- based EMS enables prehospital assessment of acute 
stroke in addition to other medical and traumatic emergencies and 
may facilitate future implementation in prehospital emergency care 
systems.
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